CEA is a tumor-specific biomarker that is commonly found in plasma, pleural fluid and ascites, and is currently detected clinically mainly by blood, which is relatively low; therefore, it is difficult to detect it precisely. This evidence concerns the gene CEACAM5 and neoplasm.